Formosa Pharmaceuticals and Samil Partner for Ophthalmic Suspension in South Korea Formosa Pharmaceuticals has signed a licensing agreement with Samil Pharmaceuticals to commercialize a new ophthalmic suspension for surgical pain relief in South Korea.

Formosa Pharmaceuticals and Samil Partner for Ophthalmic Suspension in South Korea #Taiwan #Taipei #Formosa #APP13007 #Samil

Formosa Pharmaceuticals Partners with Rxilient to Launch Innovative Ophthalmic Suspension in ASEAN Formosa Pharmaceuticals announces a groundbreaking partnership with Rxilient for the commercialization of an innovative ophthalmic treatment. This collaboration aims to enhance patient care after ocular surgeries in key ASEAN markets.

Formosa Pharmaceuticals Partners with Rxilient to Launch Innovative Ophthalmic Suspension in ASEAN #Taiwan #Taipei #Formosa_Pharmaceuticals #Rxilient #APP13007